Open the map

Alnylam PharmaceuticalsALNY

Biotech & innovation · NASDAQ · USA

$224.53
Up 0.1% todayClose

Down 43.6% this year and −22.9% since June 26, behind the life science sector at +10.7%. Alnylam Pharmaceuticals supplies 1 mapped company and buys from 1.

Market cap
$30B
This year
−43.6%
1 year
−51.2%
P/E
37.2
P/S
6.3
P/B
22.2

Price vs the life science sector

since Jun 26ALNYLife science sector, equal weight
Alnylam Pharmaceuticals (ALNY) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ALNY: −22.9% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−30%−20%−10%0%+10%Jun 26AugSepOct 8ALNY −22.9%Sector +10.7% Alnylam Pharmaceuticals (ALNY) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. ALNY: −22.9% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−20%0%Jun 26AugSepOct 8ALNY−22.9%Sector+10.7%

Supply chain

1 supplier · 1 customer
SUPPLIERS →→ CUSTOMERSCharles River Laboratories (CRL)CRLCharles River Labor…−0.8%Cencora (COR)CORCencora+1.3%ALNYAlnylam Pharmac…

Suppliers 1

Customers 1

Open the full chain →

About Alnylam Pharmaceuticals

Turns RNA interference into drugs, mostly for rare and cardiovascular disease.

Theme exposure

RNAi medicineRNAi therapyRare diseasesCardiovascular

Products

  • RNAi therapies (amyloidosis)
  • Cardiovascular RNAi
  • Research platform

Competitors

  • Ionis Pharmaceuticals
  • Pfizer
  • BridgeBio

Risks

  • Pipeline concentration
  • Competition in rare diseases

Same segment: Biotech & innovation

Innovation-driven biotech companies focused on novel treatment modalities. Segment 3 of 8 in the Medicine, pharma & life science value chain.

AmgenAMGN−1.4%Gilead SciencesGILD+0.2%Vertex PharmaceuticalsVRTX−0.5%ModernaMRNA+0.3%RegeneronREGN−0.3%BiogenBIIB−1.7%United TherapeuticsUTHR−2.2%IncyteINCY−0.6%

Compare ALNY

Side by side with the largest companies in the same segment.

ALNY vs AMGNALNY vs GILDALNY vs VRTXALNY vs MRNAALNY vs REGNALNY vs BIIB

See where Alnylam Pharmaceuticals sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →